| Responsible Regional Contact Point | |
|---|---|
| Organisation: | FLANDERSBIO |
| Contact person: | Willem Dhooge |
| Contact details: | Willem.Dhooge@flandersbio.be +32 9 241 80 46 |
| Organisation Details | |
| Founded (Year): | 0 |
| No of employees: | 250+ |
| Turnover (US $): | < 100k |
| Organisation Type: | University |
| Company (Organisation) details | |
| Areas of activity: | |
| - Medicine, Human Health | |
| 1) Technology Offer | |
| NUSAP: a novel target gene for diagnostic and treatment of cancer/immune/reproduction | |
| ABSTRACT: New nuclear spindle-associating protein and gene encoding protein for diagnosing, preventing, treating disorders of bone, immune system and those associated with DNA replication and cell proliferation, such as cancer. The invention relates to a eukaryotic nuclear protein NuSAP which is highly expressed in proliferation tissues. More specifically, NuSAP is downregulated in developing bone. NuSAP has a discrete localization in the nucleus. The localization and the expression profile indicate its role in important biological processes such as embryologic development, cell, proliferation, DNA replication and recombination. Its function relates to diseases of the immune system and diseases of the reproductive organs in particular and cancer in general. DESCRIPTION: INNOVATIVE ASPECTS: MAIN ADVANTADGES / BENEFITS: TECHNICAL SPECIFICATIONS: CURRENT STAGE OF DEVELOPMENT: INTELLECTUAL PROPERTY RIGHTS (IPR): Patents applied for but not yet granted MARKET APPLICATIONS: cancer diagnostic therapeutic TYPE OF COLLABORATION SOUGHT: License agreement Developmental collaboration PARTNER PROFILE: | |
| Market application: | |
| - Health issue diagnosis - Health issue treatment | |
| Further comments | Cancer (general) reproduction, immune disorders, bone diseases/disorders |
| Entry/Update: | 2006-11-09 / 2007-01-22 |